Articles about 'Department of Psychiatry'

Experts are warning that far from being over-diagnosed, people with ADHD are waiting too long for assessment, support and treatment.

Suicide in autistic people originates in the inequalities they face across their lives, starting in childhood, and spanning education to employment, and health and social care, a new study by a team at Cambridge and Bournemouth Universities has found.

Meet the winners of the Cambridge Awards 2025 for Research Impact and Engagement and learn more about their projects.

Cambridge researchers have revealed a detailed picture of how the human brain grows from mid-pregnancy through the first weeks after birth and identified that sex differences in brain growth are apparent from mid-pregnancy onwards.

Menopause is linked to reductions in grey matter volume in key brain regions as well as increased levels of anxiety and depression and difficulties with sleep, according to new research from the University of Cambridge.

Cambridge experts share their tips to boost your mental and physical health this year. 

Members of the collegiate University honoured for their outstanding contributions to society in science, education, medicine, the environment, and the arts.

Offering screening for neurodivergence to people detained by the police could help ensure access to appropriate support and fairer treatment in the criminal justice system, say Cambridge researchers. A study from the team suggests that one in two individuals arrested and detained in London may have undiagnosed attention-deficit/hyperactivity disorder (ADHD) and one in 20 may have undiagnosed autism.

Autistic people are more likely to report suicide-related behaviours and psychological distress irrespective of previous traumatic experiences, according to new research from the University of Cambridge.

Deep brain stimulation – implants in the brain that act as a kind of ‘pacemaker’ – has led to clinical improvements in half of the participants with treatment-resistant severe depression in an ‘open label’ trial.